Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lagresle-Peyrou C
43  Ergebnisse:
Personensuche X
?
1

AK2 deficiency compromises the mitochondrial energy metabol..:

Six, E ; Lagresle-Peyrou, C ; Susini, S...
Cell Death & Disease.  6 (2015)  8 - p. e1856-e1856 , 2015
Link: https://doi.org/10.1038/..
 
?
2

Severe hematopoietic stem cell inflammation compromises chr..:

Sobrino, S ; Magnani, A ; Semeraro, M...
https://discovery.ucl.ac.uk/id/eprint/10166108/1/1-s2.0-S2666379123000046-main.pdf.  , 2023
Link: https://discovery.ucl.ac..
 
?
3

Successful Preclinical Development of Gene Therapy for Reco..:

Garcia-Perez, L ; Van Eggermond, M ; Van Roon, L...
https://discovery.ucl.ac.uk/id/eprint/10095771/1/1-s2.0-S2329050120300462-main.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
4

Biosafety Studies of a Clinically Applicable Lentiviral Vec..:

Charrier, S ; Lagresle-Peyrou, C ; Poletti, V...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.omtm.2019.08.014.  , 2019
Link: https://hal.science/hal-..
 
?
5

Biosafety Studies of a Clinically Applicable Lentiviral Vec..:

Charrier, S ; Lagresle-Peyrou, C ; Poletti, V...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.omtm.2019.08.014.  , 2019
Link: https://hal.science/hal-..
 
?
6

Biosafety Studies of a Clinically Applicable Lentiviral Vec..:

Charrier, S ; Lagresle-Peyrou, C ; Poletti, V...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.omtm.2019.08.014.  , 2019
Link: https://hal.science/hal-..
 
?
7

Biosafety Studies of a Clinically Applicable Lentiviral Vec..:

Charrier S ; Lagresle-Peyrou C ; Poletti V...
info:eu-repo/semantics/altIdentifier/pmid/31720302.  , 2019
Link: http://hdl.handle.net/11..
 
?
8

Biosafety Studies of a Clinically Applicable Lentiviral Vec..:

Charrier, S ; Lagresle-Peyrou, C ; Poletti, V...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.omtm.2019.08.014.  , 2019
Link: https://hal.science/hal-..
 
?
9

Biosafety Studies of a Clinically Applicable Lentiviral Vec..:

Charrier, S ; Lagresle-Peyrou, C ; Poletti, V...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.omtm.2019.08.014.  , 2019
Link: https://hal.science/hal-..
 
?
10

Plerixafor enables safe, rapid, efficient mobilization of h..:

Lagresle-Peyrou C ; Lefrere F ; Magrin E...
info:eu-repo/semantics/altIdentifier/pmid/29472357.  , 2018
Link: https://hdl.handle.net/1..
 
?
11

Reticular dysgenesis: international survey on clinical pres..:

Hoenig, M ; Lagresle-Peyrou, C ; Pannicke, U...
https://discovery.ucl.ac.uk/id/eprint/1561315/1/BLOOD-2016-745638v2-Hoenig.pdf.  , 2017
Link: https://discovery.ucl.ac..
 
?
12

Gene-corrected human Munc13-4-deficient CD8+ T-cells can ef..:

Soheili, T ; Rivière, J ; Ricciardelli, I...
https://discovery.ucl.ac.uk/id/eprint/1532070/5/Amrolia_Munc%20Letter%20to%20Blood.%20%5B1%5D.pdf.  , 2016
Link: https://discovery.ucl.ac..
 
?
13

Restoration of T and B Cell Differentiation after RAG1 Gene..:

Sorel, Nataël ; Díaz-Pascual, Francisco ; Bessot, Boris...
Biomedicines.  12 (2024)  7 - p. 1495 , 2024
Link: https://doi.org/10.3390/..
 
?
14

Successful RAG1-SCID gene therapy depends on the level of R..:

Pike-Overzet, Karin ; Baum, Christopher ; Bredius, Robbert G.M....
Journal of Allergy and Clinical Immunology.  134 (2014)  1 - p. 242-243 , 2014
Link: https://doi.org/10.1016/..
 
?
15

Human adenylate kinase 2 deficiency causes a profound hemat..:

Lagresle-Peyrou, Chantal ; Six, Emmanuelle M ; Picard, Capucine...
Nature Genetics.  41 (2008)  1 - p. 106-111 , 2008
Link: https://doi.org/10.1038/..
 
1-15